Skip to content

Victoria B Risbrough

6 papers in the library · 134 citations · publishing 2008-2025

Papers

Sort Most recent Most cited

Impaired mnemonic pattern separation associated with PTSD symptoms paradoxically improves with regular cannabis use

npj Mental Health Research April 24, 2025 Jacob Ross, Bruna Cuccurazzu, Dylan Delmar et al. 1 citation

Posttraumatic stress disorder (PTSD) is associated with poor hippocampal function and disrupted pattern recognition. Cannabis use is highly prevalent in individuals with PTSD, yet the impact on these cognitive functions is poorly understood. Participants (n = 111) with a range of PTSD symptoms with and without regular cannabis use completed the mnemonic similarity task. We hypothesized that...

Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects

Frontiers in Pharmacology July 13, 2022 Patrick Vizeli, Isabelle Straumann, Urs Duthaler et al. 43 citations

Background: 3,4-Methylenedioxymethamphetamine (MDMA) has shown initial promise as an adjunct in psychotherapy to treat posttraumatic stress disorder (PTSD). Its efficacy and safety have been demonstrated across phase I–III studies. However, the mechanism underlying the potential utility of MDMA to treat PTSD in humans has not yet been thoroughly investigated. Preliminary evidence suggests that...

DOI: 10.3389/fphar.2022.906639 (opens in new tab) Full text (opens in new tab) Fear extinction Skin conductance response Fear-potentiated startle Oxytocin +1

Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia.

Neuropharmacology 2011 Maarten Van den Buuse, Emma Ruimschotel, Sally Martin et al. 37 citations

Serotonin-1A (5-HT(1A)) receptors may play a role in schizophrenia and the effects of certain antipsychotic drugs. However, the mechanism of interaction of 5-HT(1A) receptors with brain systems involved in schizophrenia, remains unclear. Here we show that 5-HT(1A) receptor knockout mice display enhanced locomotor hyperactivity to acute treatment with amphetamine, a widely used animal model of...

DOI: 10.1016/j.neuropharm.2011.04.001 (opens in new tab) Full text (opens in new tab) Schizophrenia research Psychosis model Mental health Brain disorders +12

5-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition.

Pharmacology, Biochemistry, and Behavior September 1, 2009 Vikas Duvvuri, Victoria B Risbrough, Walter H. Kaye et al. 7 citations

We propose a translational approach to the study of anorexia nervosa (AN) based on our human subject studies where there are characteristic elevations in 5-HT(1A) receptor binding, associated harm avoidance behaviors, reduced impulsivity, and comorbid anxiety disorders. Towards this goal, the hyponeophagia assay was implemented whereby food-deprived mice show increased latency to begin feeding...

DOI: 10.1016/j.pbb.2009.05.014 (opens in new tab) Full text (opens in new tab) Anxiety stress Psychological distress Apprehension Food intake +8

5-HT_2A and 5-HT_2C Receptors Exert Opposing Effects on Locomotor Activity in Mice

Neuropsychopharmacology July 1, 2009 Adam L. Halberstadt, Iris Van der Heijden, Michael A Ruderman et al.

Although it is well established that hallucinogens act as 5-HT_2A and 5-HT_2C receptor agonists, little is known about the relative contributions of 5-HT_2A and 5-HT_2C receptors to the acute behavioral effects of these drugs. The behavioral pattern monitor was used to characterize the effects of the hallucinogen 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on locomotor and investigatory...

Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.

Psychopharmacology November 1, 2008 Adam L. Halberstadt, Mahalah R Buell, Virginia L Masten et al. 46 citations

The hallucinogenic tea known as ayahuasca is made from a combination of psychoactive plants that contribute the active components N,N-dimethyltryptamine (DMT) and 5-methoxy-DMT (5-MeO-DMT), as well as the monoamine oxidase (MAO) inhibitors (MAOIs) harmine and harmaline for oral activity. The present study examined the effects of 5-MeO-DMT in combination with MAOIs in rats using the behavioral...